Ambiopharm, Inc.
FDA inspection history in North Augusta, South Carolina, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at North Augusta, South Carolina.
Cited most
Across all Ambiopharm observations on file
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
The complete Ambiopharm file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
North Augusta, South Carolina
One Form 483 · 2023 · 2 observations
Latest: Form 483, Feb 9, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-02-09 | 483 Form 483 | North Augusta, South Carolina | 2 | $99 |
Investigators on these documents
FEI number 3006446551 · most recent document Feb 9, 2023
About Ambiopharm, Inc.
How many FDA Form 483s has Ambiopharm, Inc. received?
FDA Intel has 1 Form 483 on file for Ambiopharm, Inc.; the most recent is dated Feb 9, 2023.
When was Ambiopharm, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Ambiopharm, Inc. is a Form 483 dated Feb 9, 2023, for the site in North Augusta, South Carolina.
What did FDA cite at Ambiopharm, Inc.?
The regulations cited most in the observations on file for Ambiopharm, Inc. are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.